Niacinamide

1. INCI & CAS

INCI: Niacinamide · CAS: 98-92-0

2. Role in the formula

Niacinamide is widely used in leave-on cosmetic guides around 2–5%. This is not a drug monograph claim and not a whitening drug claim.

3. Typical use levels (formulation guide)

• The formulation record indicates 2–5% for serums as a formulation guide.
• For gel-creams, the recorded level is 2–4% for the formula.
• For toners, the reference gives 2–3%.

For dissolution, use the water phase. Keep finished pH roughly 5–6.5 so it stays in the cosmetic range used by formulators.

4. Regulatory sources & global compliance

• CosIng provides reference information for Niacinamide; confirm the specific grade and intended use against market requirements.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Niacinamide to undergo a safety assessment for the product in its final form.
• Review the supplier TDS for the received Niacinamide grade, together with the target market's current filing requirements.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it does not establish drug approval or OTC-monograph status and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; review airless or pump options if oxidation presents a concern; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Niacinamide centers on niacinamide conditioning.

• This product entry does not substantiate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The ingredient record for Niacinamide cannot verify whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin serves as the polyol humectant in these cosmetic formats, while the stated percentage remains a formulation reference.

3. Typical use levels (formulation guide)

• The formulation record indicates 3–8% for gels and serums in this reference.
• 2–5% is listed for creams for the formula.
• 2–4% is listed for rinse-off as a formulation guide.

The guide places Glycerin in the water phase and calls for no melt step.

4. Regulatory sources & global compliance

• Database information on Glycerin does not replace review of the supplied grade and finished product under market rules.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Glycerin before the finished product is marketed.
• Review the documentation for the actual Glycerin grade and the filing requirements for the target market.

5. Safety & risk assessment

Use the stated level as reference guidance for cosmetic formulation; it should not be read as a drug authorization or OTC listing so patch response and stability should be checked on the finished product.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; choose a package with oxidation sensitivity in view; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• This guide frames Glycerin's cosmetic direction around humectant function.

• This ingredient reference provides no basis for a drug effect, a clinical cure, or certification status not established for the SKU.
• The information about Glycerin cannot establish whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

A plant-derived grade of squalane is specified here. It is a stable hydrocarbon emollient and is distinct from mineral oil.

3. Typical use levels (formulation guide)

• Gel-creams may use the guide range 2–6% for the formula.
• The formulation record indicates 10–30% for dry oils in this reference.
• The formulation record indicates 5–15% for balms in this reference.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• The CosIng record for Squalane, where listed, is informational rather than product-specific authorization.
• The framework in Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Squalane for the complete formula intended for sale.
• Review the supplier TDS for the received Squalane grade, together with the target market's current filing requirements.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; it provides no evidence that a drug or OTC monograph applies and the finished formula still needs patch and stability testing.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; match the pack choice to the system's oxidation risk; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• This guide frames Squalane's cosmetic direction around a light-emollient role.

• The available ingredient details is not evidence of drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• This Squalane listing offers no support for whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.